Humans are finally heading back to the moon; Cheaper weight loss drugs are coming; Milestone for LSD trials; Promise of new carbon tax

The podcast previews major science news for 2026, focusing on space missions, weight loss drugs, the medicinal use of LSD, and a European carbon border tax. Artemis II's planned mission to loop around the moon is highlighted as a crucial step toward establishing a permanent lunar presence, though the feasibility of Artemis III landing on the moon in 2027 is questioned due to reliance on SpaceX's unproven in-orbit refueling technology. The development of Orvoglipron, a GLP-1 drug in pill form, is anticipated to make weight loss treatments more accessible due to its ease of manufacturing and administration. Additionally, trials investigating LSD for anxiety reduction are discussed, noting its potential to rewire the brain and provide relief for those unresponsive to traditional treatments. Finally, the EU's carbon border tariff is presented as a means of compelling countries to reduce emissions.